Role of Cefiderocol in Multidrug-Resistant Gram-Negative Central Nervous System Infections: Real Life Experience and State-of-the-Art

• Main Authors: Alessio Sollima (Author), Francesco Rossini (Author), Paola Lanza (Author), Carlo Pallotto (Author), Marianna Meschiari (Author), Ivan Gentile (Author), Roberto Stellini (Author), Angelica Lenzi (Author), Alice Mulé (Author), Francesca Castagna (Author), Silvia Lorenzotti (Author), Silvia Amadasi (Author), Evelyn Van Hauwermeiren (Author), Barbara Saccani (Author), Benedetta Fumarola (Author), Liana Signorini (Author), Francesco Castelli (Author), Alberto Matteelli (Author)
• Format: Book
• Published: MDPI AG, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cefiderocol is a new molecule effective against multidrug-resistant (MDR) Gram-negative pathogens. Currently, there is limited evidence regarding the use of cefiderocol in central nervous system (CNS) infections. Data on the cerebrospinal fluid penetration rate of cefiderocol are limited and heterog...